A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

Respiratory syncytial virus (RSV) remains a major human pathogen, infecting the majority of infants before age two and causing re-infection throughout life. Despite decades of RSV research, there is no licensed RSV vaccine. Most candidate vaccines studied to date have incorporated the RSV fusion (F)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousa, Jarrod J., Kose, Nurgun, Matta, Pranathi, Gilchuk, Pavlo, Crowe, James E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463187/
https://www.ncbi.nlm.nih.gov/pubmed/28134924
http://dx.doi.org/10.1038/nmicrobiol.2016.271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463187/
https://www.ncbi.nlm.nih.gov/pubmed/28134924
http://dx.doi.org/10.1038/nmicrobiol.2016.271

Ejemplares similares